Job Recruitment Website - Job seeking and recruitment - Shanghai Zhangjiang Novartis Research and Development Center

Shanghai Zhangjiang Novartis Research and Development Center

The news was released this year165438+10.6, and the enterprise has not yet been built.

Novartis, a global pharmaceutical giant, announced in Shanghai today that it will establish a comprehensive biomedical research and development center in Zhangjiang High-tech Park. This is the first comprehensive R&D center established by Novartis in China. The initial research and development focused on cancers caused by infectious diseases prevalent in China and Asia, including liver cancer caused by hepatitis virus. The R&D Center will mainly employ outstanding scientists from emerging life sciences in Shanghai.

The initial investment of Novartis Shanghai R&D Center is 1 100 million USD, with a total construction area of 43,000 square meters, which can accommodate nearly 400 researchers. The first phase of the project will be put into operation in May next year. Dr. Daniel Vasella, Chairman and CEO of Novartis, said today that he believes that Shanghai R&D Center is expected to become a global biomedical innovation center.